Evidence map›Paper›PMID 39763536›Full record

ArticlemedRxiv : the preprint server for health sciences2024

Stool processing methods for Xpert Ultra testing in childhood tuberculosis: A prospective, multi-country accuracy study.

Devan Jaganath, Pamela Nabeta, Mark P Nicol, Robert Castro, Peter Wambi, Heather J Zar, Lesley Workman, Rakesh Lodha, Urvashi B Singh, Ashish Bavdekar and 13 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Devan JaganathDivision of Pediatric Infectious Diseases, University of California, San Francisco, San Francisco, USA.ORCID 0000-0002-8555-5667
Pamela NabetaFIND, Geneva, Switzerland.
Mark P NicolMarshall Centre, School of Biomedical Sciences, University of Western Australia, Perth, Australia.
Robert CastroCenter for Tuberculosis, University of California, San Francisco, San Francisco, USA.
Peter WambiWalimu, Kampala, Uganda.
Heather J ZarDepartment of Paedatrics and Child Health, University of Cape Town, Cape Town, South Africa.
Lesley WorkmanDepartment of Paedatrics and Child Health, University of Cape Town, Cape Town, South Africa.
Rakesh LodhaDepartment of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
Urvashi B SinghDepartment of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
Ashish BavdekarDepartment of Pediatrics, KEM Hospital, Pune, India.
Sonali SanghaviDepartment of Microbiology, KEM Hospital, Pune, India.
André TrollipFIND, Geneva, Switzerland.
Aurélien MaceFIND, Geneva, Switzerland.
Maryline BonnetTransVIHMH, University of Montpellier, IRD, Inserm, Montpellier, France.
Manon LounnasUniversity of Montpellier, IRD, CNRS, MIVEGEC, Montpellier, France.
Petra de HaasKNCV Tuberculosis Foundation, The Hague, The Netherlands.
Edine TiemersmaKNCV Tuberculosis Foundation, The Hague, The Netherlands.
David AllandPublic Health Research Institute, Department of Medicine, Rutgers-New Jersey Medical School, Newark, USA.
Padmapriya BanadaPublic Health Research Institute, Department of Medicine, Rutgers-New Jersey Medical School, Newark, USA.
Adithya CattamanchiCenter for Tuberculosis, University of California, San Francisco, San Francisco, USA.
Morten RuhwaldFIND, Geneva, Switzerland.
Eric WobudeyaWalimu, Kampala, Uganda.
Claudia M DenkingerFIND, Geneva, Switzerland.

Funding

Rapid Research for Diagnostics Development in TB Network (R2D2 TB Network)U01AI152087 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CATTAMANCHI, ADITHYA, DENKINGER, CLAUDIA MARIA · 2020 to 2024
$19.3M
TB detection in children using a novel stool-based GeneXpert assayR01AI131617 · NIAID · RBHS-NEW JERSEY MEDICAL SCHOOL · PI ALLAND, DAVID, NICOL, MARK PATRICK · 2018 to 2022
$2.9M
Host Proteomic Biosignatures for a Urine-based Diagnosis of Pulmonary Tuberculosis in ChildrenK23HL153581 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JAGANATH, DEVAN · 2020 to 2024
$946k
NHLBI NIH HHS K23 HL153581NIAID NIH HHS R01 AI131617NIAID NIH HHS U01 AI152087
6 · The paper itself

Abstract

Background: Centrifuge-free processing methods support stool Xpert Ultra testing for childhood tuberculosis (TB), but there are limited data on their accuracy, acceptability and usability. Methods: We conducted a prospective evaluation of stool Xpert Ultra in India, South Africa, and Uganda with three methods: Stool Processing Kit (SPK), Simple One-Step (SOS), and Optimized Sucrose Flotation (OSF). Children <15 years old with presumptive TB had respiratory specimen testing with Xpert Ultra and culture. Stool was tested using Xpert Ultra after processing with each method. We compared the accuracy of each method to a microbiological reference standard (MRS) and a composite reference standard (CRS). We surveyed the laboratory staff to assess acceptability and usability of the methods. Results: We included 607 children, of whom the median age was 3.5 years (IQR 1.3-7), 48% were female, and 15.5% were HIV positive. Against the MRS, the sensitivities of SPK, SOS and OSF were 36.9% (95% CI 28.6-45.8), 38.6% (95% CI 17.2-51), and 31.3% (95% CI 20.2-44.1), respectively. The specificities of SPK, SOS and OSF were 98.2% (95% CI 96.4-99.3), 97.3% (95% CI 93.7-99.1) and 97.1% (95% CI 93.3-99), respectively. Laboratory staff reported that the methods were acceptable and usable, but SOS was most feasible to implement in a peripheral facility. Sensitivity increased among children who were culture-positive (55-77.3%) and was low (13-16.7%) against the CRS. Conclusions: Stool processing methods for Xpert Ultra were acceptable, usable, and performed similarly, with highest sensitivity among children with culture-positive TB.

Indexed as

centrifuge-freechilddiagnosticsstooltuberculosisXpert Ultra

Identifiers

PMID39763536
PMCPMC11702738

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.